Dynamics and significance of the antibody response to SARS-CoV-2 infection

2020164 citationsPreprintgreen Open Access

Authors

Anita Iyer · Harvard University

Forrest K. Jones · Bloomberg (United States)

Ariana Nodoushani · Massachusetts General Hospital

Meagan Kelly · Massachusetts General Hospital

Margaret Becker · Massachusetts General Hospital

Damien Slater · Massachusetts General Hospital

Rachel Mills

Abstract

Among symptomatic SARS-CoV-2 cases, RBD-targeted antibodies can be indicative of previous and recent infection. IgG antibodies are correlated with neutralizing antibodies and are possibly a correlate of protective immunity.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies SARS-CoV-2 detection and testing

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: medRxiv

DOI: 10.1101/2020.07.18.20155374